Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Robert Ferrante

Thoracic Surgery (Cardiothoracic Vascular Surgery) Appleton, WI Medical Doctor

NPI 1346226826 CMS profile 714855

1818 N Meade St, Suite N347, Appleton, WI 54911

Open in the dashboard

General payments

$73,216

187 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Robert Ferrante of Appleton, WI is reported in the CMS Open Payments database as having received $73,216 across 187 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $28,005 12
2024 General $39,252 46
2023 General $1,298 28
2022 General $1,622 48
2021 General $843 27
2020 General $1,758 18
2019 General $439 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Ferrante
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Robert Ferrante were reported at $28,005. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Robert Ferrante Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $439 $886 $178–$3,167 $163
2020 $1,758 $341 $108–$1,605 $114
2021 $843 $453 $125–$1,886 $132
2022 $1,622 $695 $180–$2,566 $149
2023 $1,298 $745 $205–$2,662 $160
2024 $39,252 $799 $214–$2,967 $164
2025 $28,005 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Paragonix Technologies, Inc. $64,858 24 payments
  2. Edwards Lifesciences Corporation $2,156 52 payments
  3. Atricure, Inc. $1,664 12 payments
  4. Medtronic, Inc. $1,451 40 payments
  5. CryoLife, Inc. $960 6 payments
  6. Abiomed $814 26 payments
  7. Boston Scientific Corporation $271 3 payments
  8. Medtronic Vascular, Inc. $207 4 payments
  9. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $198 6 payments
  10. Cook Medical LLC $138 1 payment
  11. Other $497 13 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $60,400 11 payments
  2. Travel and Lodging $6,623 22 payments
  3. Food and Beverage $6,193 154 payments
Products named General payments · program years 2019–2025
  1. ATRICURE SYNERGY ABLATION SYSTEM $1,401 6 payments
  2. COREVALVE EVOLUT R $1,078 25 payments
  3. SAPIEN 3 Ultra RESILIA $971 20 payments
  4. Impella $798 25 payments
  5. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $590 14 payments
  6. ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER $531 5 payments
  7. CoreValve Evolut $341 14 payments
  8. MITRIS RESILIA Mitral Valve $234 7 payments
  9. LifeVest $198 6 payments
  10. Edwards SAPIEN 3 Transcatheter Heart Valve $175 4 payments
  11. Other $1,995 46 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 35 billing codes

Paid by Medicare

$45,922

Medicare's payments for the services billed

Medicare patients

57

Average age 78

Services billed

121

25 women, 32 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 54%
Atrial fibrillation 49%
Arthritis 47%
Chronic kidney disease 46%
Diabetes 44%
Cancer 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

187 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record